1. The Pharmaceutical Industry Ethical – prescription Highly regulated manufacturing, distribution, marketing Over the Counter/Consumer Products Discretionary Market driven

2. CGMP Current Good Manufacturing Practice – on Human use pharmaceuticals Issued by: Division of Mfg. and Product Quality Office of Compliance Center for Drug Evaluation & Research U. S. Food & Drug Administration WWW.FDA.GOV/CDER/DMPQ

3. Marketing Considerations Web Site Well constructed; complete Clearly Identify “Diversity Classification”

4. Marketing Considerations Web Site Well constructed; complete Clearly Identify “Diversity Classification” Identify your Market Size, Location, Commodity, First/Second Tier

5. Marketing Considerations Web Site Well constructed; complete Clearly Identify “Diversity Classification” Identify your Market Size, Location, Commodity, First/Second Tier Contacts Industry Memberships – ie, APA, AACP, PDE (Phila. Drug Exchange) Professional Memberships – ISM, NAWBO, NMSDC

6. Marketing Considerations Web Site Well constructed; complete Clearly Identify “Diversity Classification” Identify your Market Size, Location, Commodity, First/Second Tier Contacts Industry Memberships – ie, APA, AACP, PDE (Phila. Drug Exchange) Professional Memberships – ISM, NAWBO, NMSDC Follow Up Trade Show, professional contacts Periodic e-mails of current information Celebrate Successes Press releases, E-mail Blasts

7. Final Considerations Deliver!!!! Charles.Gillean@AstraZeneca.com 302-886-1183 Charles.Gillean@AstraZeneca.com